“Congenital Diarrheal Disorders Market” DelveInsight’s “Congenital Diarrheal Disorders Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Congenital Diarrheal Disorders, historical and forecasted epidemiology as well as the Congenital Diarrheal Disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. DelveInsight’s “Congenital diarrheal disorders – […]
Category Archives: Congenital disorders
HistoryCauses and symptomsEpidemiologyCase reports Diagnosis and treatment References Further reading Chanarin-Dorfman syndrome (CDS) is a rare, multisystemic, neutral lipid storage disease (NLSD) where the triglyceride accumulates in the leukocytes and other organs. Image Credit: ART-ur/Shutterstock.com First described by Dorfman in 1974, the syndrome follows an autosomal recessive inheritance pattern. It is caused by a mutation in the […]
Scientists have linked cilia found on cell surfaces with mechanisms for aging, and they’re hoping to help people live longer healthier lives. Nearly every cell in our body has hair-like structures on their surfaces known as cilia. These tiny, thread-like organelles perform tasks akin to those of an antenna, detecting the flow and composition of […]
Introduction Anemia is the most common hematologic abnormality identified in children and remains a major global public health problem, in both developed and developing countries. In 2019, the World Health Organization (WHO) estimated that the global prevalence of anemia in children aged 6 to 59 months was 39.8%, equivalent to 269 million children, with the […]
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) — The “Ophthalmic Examination Chairs Market Size, Share & Trends Analysis Report By Technology (Electric, Mechanical, Hydraulic, Pneumatic), By Section (2-section, 3-section, 4-section), By End-use, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global ophthalmic examination chairs market is on track […]
Abstract Gonadotropin-releasing hormone agonist (GnRHa) appears to exhibit ovarian protection during chemotherapy for malignant tumors. The purpose of this study was to analyze the benefits of GnRHa in premenopausal women undergoing hematopoietic cell transplantation (HSCT). Candidates for myeloablative chemotherapy HSCT requiring fertility preservation in the Gynecological Endocrinology Clinic of Peking University People’s Hospital from December […]